Lv1
30 积分 2021-07-21 加入
ALK in cancer: from function to therapeutic targeting
2天前
已完结
The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention
2个月前
已完结
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
3个月前
已完结
Peptidylarginine deiminases 4 as a promising target in drug discovery
5个月前
已完结
Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody-Drug Conjugate for Enhanced Anti-Tumor Efficacy in Solid Tumors
5个月前
已完结
The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention
6个月前
已完结
皖公网安备34019202002308
